Cells exposed to entorhinal cortex extracts from AD(LATE-NC+), but not AD(LATE-NC-), showed an augmented number of tau aggregates compared to cells treated with control-derived homogenates (p < 0.0001, Fig. 2b, d and Suppl. This evidence concerns the gene MAPT and Alzheimer disease.